Devices and methods of treating methamphetamine addiction and medical and behavioral consequences of methamphetamine use and of HIV infection

US10702537B2 · kind B2 · utility

Assignee

• BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE · US

Inventors

• Nicholas E. Goeders · Shreveport, US
• Christopher Dalton Schmoutz · Shreveport, US

Key dates

• Filing date: Jun 4, 2018
• Grant date: Jul 7, 2020
• Expiry date: Jun 4, 2038

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K45/06
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A method of treating a condition of in a human patient comprising pharmacologically activating a translocator protein of 18 kDa (TSPO), wherein the condition is one of a chronic methamphetamine addiction, a medical consequence of methamphetamine use; a behavioral consequence of methamphetamine use, an HIV associated cognitive motor disorder, an HIV-associated neurodegenerative disorder, and a neuroinflammatory response.